Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 97

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 97
---
 by Leerink Partners in preparing its opinion, is attached as Annex C to this proxy statement and is incorporated herein by reference. The summary of the written opinion of Leerink Partners set forth below is qualified in its entirety by the full text of the written opinion attached hereto as Annex C. Leerink Partners’ financial advisory services and opinion were provided for the information and assistance of Aadi’s board of directors (in their capacity as directors and not in any other capacity) in connection with and for purposes of Aadi’s board of directors’ consideration of the Divestiture and the opinion of Leerink Partners addressed only the fairness, from a financial point of view, as of the date thereof, to Aadi of the consideration proposed to be paid to Aadi pursuant to the terms of the Divestiture Agreement. The opinion of Leerink Partners did not address any other term or aspect of the Divestiture Agreement or the Divestiture and does not constitute a recommendation to any stockholder of Aadi as to whether or how such holder should vote with respect to the Divestiture or otherwise act with respect to the Divestiture or any other matter. The full text of the written opinion of Leerink Partners should be read carefully in its entirety for a description of the assumptions made and the qualifications and limitations upon the review undertaken by Leerink Partners in preparing its opinion. In connection with rendering the opinion described above and performing its related financial analyses, Leerink Partners reviewed, among other things:

| • |     | certain Current Reports on Form 8-K, as filed by Aadi with, or furnished 
 by Aadi to, the SEC; and                                                 |

| • |     | certain internal information relating to the business, operations, earnings, cash flow, assets, liabilities and                                                                                                                             
 prospects of Aadi, including certain financial forecasts related to Aadi Sub, as furnished to Leerink Partners by the management of Aadi for purposes of Leerink Partners’ analysis and approved for use by Leerink Partners by Aadi, which 
 financial forecasts are described above under “The Divestiture – Certain Unaudited Prospective Financial Information” and referred to in this summary of the opinion of Leerink Partners as the “Aadi Projections”, and                     
 which are collectively referred to in this summary of the opinion of Leerink Partners as the “Internal Data.”                                                                                                                               |

Leerink Partners also conducted discussions with members of the senior management of Aadi and its advisors and representatives regarding the Internal Data as well as the past and current business,